Prostacyclin-lipoprotein interactions

This publication has 35 references indexed in Scilit:

• Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
  New England Journal of Medicine, 1984
• The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes
  Prostaglandins, 1984
• Prostacyclin in aortocoronary bypass surgery: A double-blind, placebo-controlled study
  Thrombosis Research, 1983
• Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia
  Biochemical Pharmacology, 1983
• Platelets from diabetic subjects show diminished sensitivity to prostacyclin
  European Journal of Clinical Investigation, 1982
• Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris
  The American Journal of Cardiology, 1980
• Arterial platelet accumulation in experimental hypercholesterolemia
  Atherosclerosis, 1980
• PROSTACYCLIN GENERATION IN ATHEROSCLEROTIC ARTERIES
  The Lancet, 1979
• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
  Prostaglandins, 1977
• Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
  Prostaglandins, 1976